News for Ultragenyx Pharmaceutical Inc. (UP0.F)

Players in the microneedle drug delivery system market are leveraging growing demand for minimally invasive, pain-free therapeutic options for infectious and

In this article we talk about 15 fastest growing biotech companies in the US. You can skip our detailed analysis of the biotech industry and go to 5 Fastest...

Guru adds to health care holdings with biotech focused on cancer, serious diseases

Steven Cohen Dives Into Chimerix, Stocks: CMRX,ALNY,DRNA,MRTX,GLPG,CRIS,AGLE,ATRA,BLU,BDTX, Steven Cohen, release date:Feb 24, 2021

Steven Cohen Dives Into Chimerix, Stocks: CMRX,ALNY,DRNA,MRTX,GLPG,CRIS,AGLE,ATRA,BLU,BDTX, Steven Cohen, release date:Feb 24, 2021

NOVATO, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development and ...

LONDON and REDWOOD CITY, Calif., Feb. 12, 2021 -- Mereo BioPharma Group plc , a clinical-stage biopharmaceutical company focused on oncology and rare diseases, announced the closing of its... | February 12, 2021

Upgrades According to Citigroup, the prior rating for YETI Holdings Inc (NYSE:YETI) was changed from Neutral to Buy. In the fourth quarter, YETI Holdings ...

The following slide deck was published by Ultragenyx Pharmaceutical Inc.

The following slide deck was published by Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q4 2020 Earnings Conference Call February 11, 2021 05:00 PM ET Company Participants Joshua Higa - Director, Investor Relations Emil Kakkis -...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 11) 10X ...

Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vaccine updates, M&A acti...

Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vaccine updates, M&A activity, IPO ...